SPONSOR
University Hospital Schleswig-Holstein
Total Trials
5
Recruiting
5
Phases
Phase 2
Conditions studied: Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)Medical OncologyPalliative CareQuality of LifeCannabinoidsAtopic Dermatitis (Moderate-to-severe) Involving the Genital RegionParkinson DiseaseNutritional and Metabolic DiseasesSugar IntakeProstate Cancer
University Hospital Schleswig-Holstein is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Medical Oncology, Palliative Care, Quality of Life.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University Hospital Schleswig-Holstein
How many clinical trials has University Hospital Schleswig-Holstein sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by University Hospital Schleswig-Holstein, of which 5 are actively recruiting participants. These trials cover conditions including Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Medical Oncology, Palliative Care. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Hospital Schleswig-Holstein research focus on?
University Hospital Schleswig-Holstein clinical trials span Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Medical Oncology, Palliative Care, Quality of Life, Cannabinoids, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Hospital Schleswig-Holstein clinical trial?
To participate in a University Hospital Schleswig-Holstein trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital Schleswig-Holstein trials with current recruitment status updated daily.
Clinical Trials by University Hospital Schleswig-Holstein
NCT07286747 Phase 2
Recruiting
Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT)
Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
NCT06097533 Phase 2
Recruiting
Improvement of Quality of Life by Cannabinoids in Oncologic Patients
Medical Oncology
NCT07444801
Recruiting
Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact
Atopic Dermatitis (Moderate-to-severe) Involving the Genital Region
NCT05998772
Recruiting
Influence of Glucose on Metabolism and Clinical Symptoms of Patients With Parkinson's Disease
Parkinson Disease
NCT06914544
Recruiting
Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III)
Prostate Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology